Invention Grant
US09012644B2 Compounds having muscarinic receptor antagonist and beta2 adrenergic receptor agonist activity
有权
具有毒蕈碱受体拮抗剂和β2肾上腺素能受体激动剂活性的化合物
- Patent Title: Compounds having muscarinic receptor antagonist and beta2 adrenergic receptor agonist activity
- Patent Title (中): 具有毒蕈碱受体拮抗剂和β2肾上腺素能受体激动剂活性的化合物
-
Application No.: US13492188Application Date: 2012-06-08
-
Publication No.: US09012644B2Publication Date: 2015-04-21
- Inventor: Fabio Rancati , Andrea Rizzi , Ian Linney , Wesley Blackaby , Chris Knight
- Applicant: Fabio Rancati , Andrea Rizzi , Ian Linney , Wesley Blackaby , Chris Knight
- Applicant Address: IT Parma
- Assignee: Chiesi Farmaceutici S.p.A.
- Current Assignee: Chiesi Farmaceutici S.p.A.
- Current Assignee Address: IT Parma
- Agency: Oblon, McClelland, Maier & Neustadt, L.L.P.
- Priority: EP11169535 20110610
- Main IPC: C07D453/04
- IPC: C07D453/04 ; A61K31/47 ; C07D401/12 ; C07D409/14 ; C07D417/12
Abstract:
Compounds of formula (I) act both as muscarinic receptor antagonists and beta2 adrenergic receptor agonists and are useful for treating and/or preventing broncho-obstructive and inflammatory diseases.
Public/Granted literature
- US20130034504A1 COMPOUNDS HAVING MUSCARINIC RECEPTOR ANTAGONIST AND BETA2 ADRENERGIC RECEPTOR AGONIST ACTIVITY Public/Granted day:2013-02-07
Information query
